FARLETUZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Fri Dec 15 17:26:56 GMT 2023` Edited by `admin` on `Fri Dec 15 17:26:56 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	2O09BG0OWA
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FARLETUZUMAB

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER

Common Name

English

FARLETUZUMAB [USAN]

Common Name

English

FARLETUZUMAB [JAN]

Common Name

English

MORAB-003

Code

English

Farletuzumab [WHO-DD]

Common Name

English

FARLETUZUMAB [MART.]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER

Common Name

English

farletuzumab [INN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

204905

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

Code System Code Type Description

DRUG BANK

DB05595

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

NCI_THESAURUS

C61503

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

USAN

TT-118

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

CAS

896723-44-7

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

ChEMBL

CHEMBL1743016

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

EVMPD

SUB33728

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

INN

9067

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

FDA UNII

2O09BG0OWA

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

WIKIPEDIA

FARLETUZUMAB

Created by admin on Fri Dec 15 17:26:56 GMT 2023 , Edited by admin on Fri Dec 15 17:26:56 GMT 2023

PRIMARY

From	To
1_22	1_96
1_146	1_202
1_222	3_217
1_228	2_228
1_231	2_231
1_263	1_323
1_369	1_427
2_22	2_96
2_146	2_202
2_222	4_217
2_263	2_323
2_369	2_427
3_23	3_89
3_137	3_197
4_23	4_89
4_137	4_197

Glycosylation Link Type	Site
N	1_299
N	2_299

Related Record Type Details


					I9G3JZ25IH

FOLATE RECEPTOR ALPHA

TARGET -> INHIBITOR


					UVG3B5TZN3

FARLETUZUMAB ECTERIBULIN

CONJUGATE -> PARENT

Amount:

Related Record Type Details


					2O09BG0OWA

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:SEQUENCE(CALCULATED)	CHEMICAL